📈 Stocks · US

Crocs CROX · Analysis & News

Stocks US ISIN US2270461096
News situation · News, 30 days · no price data
▬ Neutral weak Data coverage thin
Price no dataTrend no price dataNews none in 30 days

Heads-up: USD CPI y/y is due in 29 min (high impact). The outlook can shift noticeably around it.

Heads-up: USD Core CPI m/m is due in 29 min (high impact). The outlook can shift noticeably around it.

Heads-up: USD CPI is due in 29 min (high impact). The outlook can shift noticeably around it.

Heads-up: USD CPI m/m is due in 29 min (high impact). The outlook can shift noticeably around it.

Heads-up: USD Core CPI n.s.a. m/m is due in 29 min (high impact). The outlook can shift noticeably around it.

Heads-up: USD Core CPI is due in 29 min (high impact). The outlook can shift noticeably around it.

Heads-up: USD Core CPI y/y is due in 29 min (high impact). The outlook can shift noticeably around it.

  • Crocs sits in balance: a director's September share purchase points to insider confidence, while margin compression and a weak share price pull the other way.
  • The Q3 conference call scheduled for October 29 has passed, and nothing in the news record since the October 8 announcement revisits margins or guidance.
  • That September purchase, 4,000 shares for $437,520 at roughly $109.38 each, is the level the fundamental work treats as a floor.
  • All three horizons read neutral, and with no technical signals in play the whole picture rests on this company-level evidence.
News situation · 0 items / 30 D
▬ Neutral weak Data coverage thin
AI-generated · as of November 4, 2026
News, 30 days
Neutral
Outlook

Outlook for Crocs, Inc.

Direction, typical moves and upcoming dates from our own price, news and calendar data, recalculated on every visit. An assessment, not investment advice.

What drives it
  • A director bought 4,000 shares for $437,520 in September, the clearest expression of insider confidence in the recent record.
  • That purchase price, about $109.38, is the level the fundamental work treats as a floor under the shares.
  • The insider confidence implies management expects margin trends to improve, the constructive thread running through an otherwise neutral view.
What argues against it
  • Margin compression and the recent run of share-price weakness are the counterweight; without evidence of stabilisation, the insider's level is only a floor for now.
  • The late-October Q3 report is already behind us, and the read-across to margins and forward guidance is the next real test of the recovery case.
  • Support near $109.38 carries much of the bullish argument; a sustained move below it would weaken that reading.
  • US jobless claims, payrolls, unemployment and CPI are due over the coming days; for a consumer-facing stock they set the backdrop but give no clear direction here.
Coming up
  • US: Consumer prices · expected 4.2%, previous 3.7%
  • US: Jobless claims
All dates ↓ All times UTC.

Economic data for CROX

Full calendar

Coming up

  • TodayUSDCPI y/y●●●Forecast 4.2%Previous 3.7%in 29m
  • TodayUSDCore CPI m/m●●●Forecast 0.2%Previous 0.3%in 29m
  • TodayUSDCPI●●●Forecast 338.683Previous 336.298in 29m
  • TodayUSDCPI m/m●●●Forecast 0.5%Previous 0.6%in 29m
  • TodayUSDCore CPI n.s.a. m/m●●●Previous 0.4%in 29m
  • TodayUSDCore CPI●●●Forecast 339.796Previous 338.896in 29m
  • TodayUSDCore CPI y/y●●●Forecast 2.8%Previous 2.6%in 29m
  • November 12, 2026USDInitial Jobless Claims●●●in 2 days

All times UTC. Assessed against the consensus forecast, otherwise against the previous value.

Signal history

Both worlds over time

Technical and news signals of the last 90 days on one timeline.

Bullish ▲Bearish ▼17.09. · News signal · Impact 4/1008.10. · News signal · Impact 2/10
90 days ago today
Technical signal News signal Size = strength
Full analysis

In-depth analysis of Crocs, Inc.

AI-generated · as of November 4, 2026

Crocs is a stock without a strong directional case at the moment, and the balance of what is known explains why. The one signal with real weight is a September purchase by director Thomas J. Smach, who bought 4,000 shares for $437,520, or roughly $109.38 each.

Read full analysis

Insider buying at that scale is usually read as management seeing value in its own shares, and it lines up with the support level the fundamental work marks near the purchase price. Against it sits the reason the shares were cheap enough to attract a buyer: margin compression and a stretch of share-price underperformance that has not yet been shown to have turned. News flow since has been thin. The October 8 announcement of the Q3 conference call carried no financial detail, and that call, scheduled for October 29, has now passed; nothing in the recent record revisits margins or guidance afterwards. So the near and medium term look sideways, and the longer view stays neutral too, because the constructive insider signal is not yet backed by confirmed profitability. There are no technical signals on the other side of the ledger, which leaves the picture resting entirely on this company-level evidence. What would settle it is a clear read on margin trends and forward guidance, and how the shares behave around the insider's buying level.

Frequently asked questions about Crocs, Inc.

What is actually driving Crocs shares right now?

Two forces are pulling against each other. On the supportive side, director Thomas J. Smach bought 4,000 shares for $437,520, roughly $109.38 each, a purchase usually read as insiders seeing value at current prices. On the other side, margin compression and a stretch of share-price underperformance have not been shown to have reversed. Because neither force has been confirmed by fresh numbers, the near, medium and long views all come out neutral rather than leaning one way.

What does the September insider purchase tell us?

It is the strongest single signal in the recent record. A board member committing $437,520 of his own money for 4,000 shares, at about $109.38 each, suggests management views the shares as undervalued after their weak run. Insider buying is one person's judgement rather than a company forecast, so it supports the case for a floor near that price without proving margins have turned. It is the main reason the downside case is not stronger than it is.

What would shift the neutral view?

A clear read on margin trends and forward guidance would do most of the work. If profitability is shown to be stabilising while the shares hold above the insider's buying level near $109.38, the constructive case gains the confirmation it currently lacks. If margins keep deteriorating or the shares settle below that level, the insider-confidence argument weakens and the balance tips the other way. Until one of those happens, the evidence points in both directions at once.

How much should the Q3 earnings date matter now?

The conference call was scheduled for October 29 and has already taken place, so it is no longer a forthcoming catalyst. What matters now is the read-across from that report: whether margin trends and forward guidance back up the recovery the insider purchase implies. The only other item in the recent news flow was the October 8 announcement of the call itself, which carried no financial detail. Any follow-up commentary on profitability is the thing to watch.

Asset Snapshot

📝 Overview Generated automatically

CROX has been the subject of 3 signals across 3 articles in the last 365 days. Sentiment skews Neutral (67%).

Breakdown: 1 bullish, 0 bearish, 2 neutral.